Details for 2016185090

Up to date per 04.04.2026

Actions

Title / Product Name

KOMBINATION VON ANTI-CD20-ANTIKÖRPERN UND PI3-KINASESELEKTIVEM INHIBITOR

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016185090

EP Publication Number

3150256

E-Number

1290321

Language

PCT Number

Publication Date

05.04.2017 A

15.07.2020 B1

Registration Date

15.07.2020

AT Publication Date

15.08.2020

Application Date

01.11.2013

Registration Number

Priorities

02.11.2012

4595CH2012

02.03.2013

201361771812 P

IPC

A61P 35/00 20060101AFI20161214BHEP

Maximum Duration of Protection

01.11.2033

Owner

TG Therapeutics Inc.2 Gransevoort Street, 9th Floor New York, NY 10014US

Rhizen Pharmaceuticals S.A.Fritz Courvoisier 40 2300 La Chaux de FondsCH

Laboratoire Français du Fractionnement et des Biotechnologies3, avenue des Tropiques, ZA Courtaboeuf, 91940 Les UlisFR

Representative

Michael Dipl.Ing. Mag. BabelukFlorianigasse 26/31080 WienAT

Inventor

Weiss, Michael2 Gansevoort St., 9th Floor New York, NY 10014US

Miskin, Hari2 Gansevoort St., 9th Floor New York, NY 10014US

Sportelli, Peter2 Gansevoort St., 9th Floor New York, NY 10014US

Vakkalanka, Swaroop K.V.SRhizen Pharmaceuticals S.A. Fritz Courvoisier 40 2300 La Chaux de FondsCH